|
JP5197016B2
(ja)
|
2004-12-23 |
2013-05-15 |
デシファラ ファーマスーティカルズ， エルエルシー |
酵素モジュレータ及び治療
|
|
DE102006029795A1
(de)
*
|
2006-06-27 |
2008-01-03 |
Schebo Biotech Ag |
Neue Harnstoff-Derivate und deren Verwendungen
|
|
WO2008026704A1
(en)
*
|
2006-08-31 |
2008-03-06 |
Kyowa Hakko Kogyo Co., Ltd. |
Isoquinoline derivative
|
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
|
US8188113B2
(en)
*
|
2006-09-14 |
2012-05-29 |
Deciphera Pharmaceuticals, Inc. |
Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US7790756B2
(en)
|
2006-10-11 |
2010-09-07 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
US7678792B2
(en)
|
2006-10-20 |
2010-03-16 |
Irm Llc |
Compositions and methods for modulating c-kit and PDGFR receptors
|
|
CA2668190A1
(en)
*
|
2006-11-03 |
2008-05-15 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
|
US20110189167A1
(en)
*
|
2007-04-20 |
2011-08-04 |
Flynn Daniel L |
Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
|
|
AU2008242720A1
(en)
*
|
2007-04-20 |
2008-10-30 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
|
EA019524B1
(ru)
|
2007-05-04 |
2014-04-30 |
Айрм Ллк |
СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ с-kit И PDGFR
|
|
AU2008289037B2
(en)
|
2007-08-22 |
2012-03-01 |
Novartis Ag |
5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
|
|
JP5303557B2
(ja)
|
2007-08-22 |
2013-10-02 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
キナーゼ阻害剤である２−ヘテロアリールアミノ−ピリミジン誘導体
|
|
BRPI0908849A2
(pt)
*
|
2008-02-22 |
2015-08-25 |
Irm Llc |
Composto e composições como c-kit e inibidores de pdgfr quinase
|
|
EP2321262A1
(de)
|
2008-08-14 |
2011-05-18 |
Bayer CropScience AG |
Insektizide 4-phenyl-1h-pyrazole
|
|
BRPI0920707A2
(pt)
|
2008-10-02 |
2015-12-29 |
Respivert Ltd |
compostos
|
|
GB0818033D0
(en)
|
2008-10-02 |
2008-11-05 |
Respivert Ltd |
Novel compound
|
|
EP2365752B1
(en)
*
|
2008-10-29 |
2014-09-24 |
Deciphera Pharmaceuticals, Llc |
Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
|
|
WO2010067130A1
(en)
|
2008-12-11 |
2010-06-17 |
Respivert Limited |
P38 map kinase inhibitors
|
|
GB0905955D0
(en)
|
2009-04-06 |
2009-05-20 |
Respivert Ltd |
Novel compounds
|
|
WO2012125981A2
(en)
*
|
2011-03-17 |
2012-09-20 |
Selexagen Therapeutics, Inc. |
Raf kinase inhibitors
|
|
MY173181A
(en)
|
2011-05-13 |
2020-01-02 |
Array Biopharma Inc |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
|
|
MX2014000963A
(es)
|
2011-07-26 |
2014-03-27 |
Gruenenthal Gmbh |
Derivados de carboxamida y urea aromaticos biciclicos sustituidos como ligandos del receptor de vanilloide.
|
|
GB201113538D0
(en)
|
2011-08-04 |
2011-09-21 |
Karobio Ab |
Novel estrogen receptor ligands
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
EP2922844B1
(en)
|
2012-11-13 |
2018-01-10 |
Array Biopharma, Inc. |
N-pyrrolidinyl, n'-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9790178B2
(en)
|
2012-11-13 |
2017-10-17 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
WO2014078328A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078325A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078331A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
WO2014078378A1
(en)
|
2012-11-13 |
2014-05-22 |
Array Biopharma Inc. |
Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors
|
|
US9822118B2
(en)
|
2012-11-13 |
2017-11-21 |
Array Biopharma Inc. |
Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
EP2920166B1
(en)
|
2012-11-13 |
2016-11-02 |
Array Biopharma, Inc. |
Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain
|
|
US9981959B2
(en)
|
2012-11-13 |
2018-05-29 |
Array Biopharma Inc. |
Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors
|
|
US9809578B2
(en)
|
2012-11-13 |
2017-11-07 |
Array Biopharma Inc. |
Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors
|
|
LT3154959T
(lt)
|
2014-05-15 |
2019-09-25 |
Array Biopharma, Inc. |
1-((3s,4r)-4-(3-fluorfenil)-1-(2-metoksietil)pirolidin-3-il)-3-(4-metil-3-(2-metilpirimidin-5-il)-1-fenil-1h-pirazol-5-il)karbamidas kaip trka kinazės inhibitorius
|
|
GB201721185D0
(en)
|
2017-12-18 |
2018-01-31 |
Nodthera Ltd |
Sulphonyl urea derivatives
|
|
EA202091763A1
(ru)
|
2018-01-31 |
2020-12-14 |
ДЕСИФЕРА ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Комбинированная терапия для лечения мастоцитоза
|
|
SG11202007198WA
(en)
|
2018-01-31 |
2020-08-28 |
Deciphera Pharmaceuticals Llc |
Combination therapy for the treatment of gastrointestinal stromal tumors
|
|
WO2019241311A1
(en)
*
|
2018-06-11 |
2019-12-19 |
Northeastern University |
Selective ligands for modulation of girk channels
|
|
CN109134451A
(zh)
*
|
2018-09-10 |
2019-01-04 |
遵义医学院 |
1,3-二取代脲类与硫脲类衍生物及其应用
|
|
EP3886854A4
(en)
|
2018-11-30 |
2022-07-06 |
Nuvation Bio Inc. |
Pyrrole and pyrazole compounds and methods of use thereof
|
|
CN109456280B
(zh)
*
|
2018-12-24 |
2020-11-10 |
锦州医科大学 |
含有脲结构的4-苯基噻唑-2-胺类衍生物及其制备方法与应用
|
|
EP3938363A1
(en)
|
2019-03-11 |
2022-01-19 |
Teva Pharmaceuticals International GmbH |
Solid state forms of ripretinib
|
|
SMT202400291T1
(it)
|
2019-06-12 |
2024-09-16 |
Nodthera Ltd The Mansion |
Derivati di solfonilurea e loro usi
|
|
WO2021013712A1
(en)
|
2019-07-19 |
2021-01-28 |
Anagenesis Biotechnologies S.A.S. |
Polyaromatic urea derivatives and their use in the treatment of muscle diseases
|
|
JP7818502B2
(ja)
|
2019-08-12 |
2026-02-20 |
デシフェラ・ファーマシューティカルズ，エルエルシー |
胃腸間質腫瘍を治療するためのリプレチニブ
|
|
WO2021030405A1
(en)
|
2019-08-12 |
2021-02-18 |
Deciphera Pharmaceuticals, Llc |
Ripretinib for treating gastrointestinal stromal tumors
|
|
TWI837402B
(zh)
*
|
2019-12-20 |
2024-04-01 |
大陸商深圳艾欣達偉醫藥科技有限公司 |
含氟化合物、含氟化合物之製備方法及其抗癌醫藥用途
|
|
SI4084778T1
(sl)
|
2019-12-30 |
2024-01-31 |
Deciphera Pharmaceuticals, Llc |
Formulacije inhibitorja amorfne kinaze in načini njihove uporabe
|
|
AU2020417282B2
(en)
|
2019-12-30 |
2023-08-31 |
Deciphera Pharmaceuticals, Llc |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
|
|
EP4029501A1
(en)
|
2021-01-19 |
2022-07-20 |
Anagenesis Biotechnologies |
Combination of polyaromatic urea derivatives and glucocorticoid or hdac inhibitor for the treatment of diseases or conditions associated with muscle cells and/or satellite cells
|
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|